The answer is "it should be," says columnist. That way, sickle cell patients could receive the support that they need.

Standard treatments can significantly lower the risk of stroke in children with sickle cell anemia, according to a review of ...

Winter is one of columnist Michelle Harlan's favorite seasons, but having sickle cell disease means navigating this time of ...

A $3 million donation from Big Nova supports NMDP programs that reduce barriers to blood stem cell transplants.

A Phase 1b trial shows the higher dose of pociredir boosts fetal hemoglobin levels in adults with sickle cell disease.

Risto-cel, a gene-edited cell therapy formerly called BEAM-101, for severe SCD, benefits patients for nearly two years, new ...

A lack of accessibility in a non-inclusive society for those with a disability comes at a terrible cost, writes columnist.

The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta (voxelotor) — withdrawn from the market ...

A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD) learn about and communicate with their care team about their pain attacks. People with ...

The Centers for Medicare & Medicaid Services (CMS) has announced that 33 states, along with the District of Columbia and Puerto Rico, have agreed to participate in the Cell and Gene Therapy (CGT) ...

A student at Kennesaw State University in Georgia is helping to develop a low-cost, light-based device to screen for stroke in children with sickle cell disease (SCD) by monitoring how well their ...

A European Medicines Agency committee has issued a positive opinion on the gene-editing therapy Casgevy (exagamglogene autotemcel) in treating sickle cell disease (SCD) and transfusion-dependent beta ...